$REPL

Replimune Group Inc

  • NASDAQ
  • Health Technology
  • Biotechnology

PRICE

$8.63 ▼-0.918%

Delayed Price

VOLUME

255,973

DAY RANGE

-

52 WEEK

5.89 - 24.81

Join Discuss about REPL with like-minded investors

profile
@dros #droscrew
recently

$CNK Oct 18 C $JD Jan 38.76 C $REPL Nov 17.5 C $ARKG Nov 29 C $IQ Nov 5.5 C $ASHR Oct13 25 P $BMBL Nov 10 P $ELAN Oct 11 P $EWC Oct 32 P $LSXMA Jan 22.5 P $BX Oct06 100 P $AMD Oct27 98 P $VALE Dec 12 P $GGAL Jan 7.5 P $BAC Oct06 26 P $ONON Oct06 25 P

79 Replies 10 👍 7 🔥

profile
@dros #droscrew
recently

$CNK Oct 18 C $JD Jan 38.76 C $REPL Nov 17.5 C $ARKG Nov 29 C $IQ Nov 5.5 C $ASHR Oct13 25 P $BMBL Nov 10 P $ELAN Oct 11 P $EWC Oct 32 P $LSXMA Jan 22.5 P $BX Oct06 100 P $AMD Oct27 98 P $VALE Dec 12 P $GGAL Jan 7.5 P $BAC Oct06 26 P $ONON Oct06 25 P

149 Replies 7 👍 7 🔥

profile
@Neptune5045 #StockTraders.NET
recently

$REPL ripping

127 Replies 15 👍 11 🔥

profile
@viking #StockTraders.NET
recently

stopped $REPL 34.50 great trade

98 Replies 10 👍 12 🔥

profile
@viking #StockTraders.NET
recently

added to $REPL 33.30 , roll down stop to 34.50

115 Replies 14 👍 14 🔥

profile
@viking #StockTraders.NET
recently

alright rolling down $REPL stop to 36, maybe it will gap down. back to coding my IB bot

144 Replies 7 👍 15 🔥

profile
@viking #StockTraders.NET
recently

that was @WINTERTRADE $REPL call

150 Replies 10 👍 8 🔥

profile
@maletone #StockTraders.NET
recently

good call on the $REPL helped me have a bigger green day then yesterday

137 Replies 8 👍 7 🔥

profile
@viking #StockTraders.NET
recently

added to $REPL 37.. roll up stop to 41

119 Replies 12 👍 9 🔥

JC
@JCrow #StockTraders.NET
recently

WOW! nice > @WINTERTRADE said: ss some REPL

150 Replies 12 👍 13 🔥

EB
@Ebadtothebone #StockTraders.NET
recently

some good timing there > @WINTERTRADE said: ss some REPL

58 Replies 8 👍 15 🔥

profile
@viking #StockTraders.NET
recently

$REPL 42.18 ave., 45.13 stop

77 Replies 15 👍 9 🔥

WI
@WINTERTRADE #StockTraders.NET
recently

ss some REPL

136 Replies 12 👍 10 🔥

EB
@Ebadtothebone #StockTraders.NET
recently

$REPL up a casual 80% on the day

40 Replies 11 👍 10 🔥

WI
@WINTERTRADE #StockTraders.NET
recently

ss REPL some

81 Replies 13 👍 13 🔥

Key Metrics

Market Cap

534.69 M

Beta

0.87

Avg. Volume

1.52 M

Shares Outstanding

61.39 M

Yield

0%

Public Float

0

Next Earnings Date

2024-05-16

Next Dividend Date

Company Information

replimune group, inc., a biotechnology company, develops oncolytic immune-gene therapies to treat cancer. it uses its proprietary immulytic platform to design and develop product candidates that are intended to activate the immune system against cancer. the company's lead product candidate is rp1, a selectively replicating version of herpes simplex virus 1, which is in phase i/ii clinical trials for a range of solid tumors; and that is in phase ii clinical trials for patients with cutaneous squamous cell carcinoma. it is also developing rp2, which is in phase i clinical trials for an anti-ctla-4 antibody-like protein in order to block the inhibition of the immune response otherwise caused by ctla-4; and rp3 to express immune-activating proteins that stimulate t cells. replimune group, inc. was founded in 2015 and is headquartered in woburn, massachusetts.

CEO: philip Astley-Sparke

Website:

HQ: 500 Unicorn Park Dr Woburn, 01801-3377 Massachusetts

Related News